Dr. Thomas A Papin, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 20 12th Ave Nw, Ardmore, OK 73401 Phone: 580-223-3411 Fax: 580-226-6213 |
Dr. Joel Sabangan, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1514 Meadow Ln, Ardmore, OK 73401 Phone: 580-223-5919 Fax: 580-220-2810 |
News Archive
Look deep inside the brain of someone with Alzheimer's disease, most forms of dementia or the concussion-related syndrome known as chronic traumatic encephalopathy (CTE) and you'll find a common suspected culprit: stringy, hairball-like tangles of a protein called tau.
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
The next time you are struggling to carry your bags home from the supermarket just remember that this could, in fact, be the reason you are able to walk upright on two legs at all!
Senate Democrats will begin the new week by taking on one of the most divisive issues for their caucus: abortion. The Associated Press reports Democratic leaders are hoping a pep talk by President Obama Sunday and ongoing negotiations on the topic will buttress their effort to address the issue and move on. Sen. Ben Nelson, D-Neb., an anti-abortion centrist, introduced an amendment that would ban private health plans that receive federal subsidies from covering abortions, even if they are paid for by patients' premiums, much as the House has done. Liberals say that language is too restrictive.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which evaluated samples from 2,137 patients, suggest that the PAM50-based Prosignaz Breast Cancer Prognostic Gene Signature Assay may help identify women with late distant recurrence after five years of endocrine treatment.
› Verified 1 days ago